As advised via PHARMAC tender of 29 June 2018 there is to be a change in the listing and future sole supply.

New listing from 1 November 2018

Nausicalm Tab 50 mg 10                          Pharmacode 2231220                   Schedule price $0.55

Incumbent brand

Nauzene Tab 50 mg 20                            Pharmacode 2488655                  Schedule price $0.59

Reference pricing will not apply. HML (Hospital Supply Status) will be implemented 1 January 2019 and CSS (Community Supply Status) 1 April 2019.

As of the date of this notification ProPharma / PWR cannot accept Nauzene Tab 50 mg 20 for credit under any circumstances.

We would recommend you continue to purchase the incumbent and we will change automatically as existing stocks are exhausted.

Once again we need your support to ensure stock in the supply chain moves through, to effectively ensure no losses are incurred.

Together we can make this a seamless and painless transition.

We thank you in anticipation of your ongoing support.

About The Author